Abstract:Objectives Based on genetic associations, McGonagle and McDermott suggested a classification of autoimmune and autoinflammatory diseases as a continuum ranging from purely autoimmune to purely autoinflammatory diseases and comprising diseases with both components. We used deep immunophenotyping to identify immune cell populations and molecular targets characterising this continuum. Methods We collected blood from 443 patients with one of 15 autoimmune or autoinflammatory diseases and 71 healthy volunteers. Deep phenotyping was performed using 13 flow cytometry panels characterising over 600 innate and adaptive cell populations. Unsupervised and supervised analyses were conducted to identify disease clusters with their common and specific cell parameters. Results Unsupervised clustering categorised these diseases into five clusters. Principal component analysis deconvoluted this clustering into two immunological axes. The first axis was driven by the ratio of LAG3+ to ICOS+ in regulatory T lymphocytes (Tregs), and segregated diseases based on their inflammation levels. The second axis was driven by activated Tregs and type 3 innate lymphoid cells (ILC3s), and segregated diseases based on their types of affected tissues. We identified a signature of 23 cell populations that accurately characterised the five disease clusters. Conclusions We have refined the monodimensional continuum of autoimmune and autoinflammatory diseases as a continuum characterised by both disease inflammation levels and targeted tissues. Such classification should be helpful for defining therapies. Our results call for further investigations into the role of the LAG3+/ICOS+ balance in Tregs and the contribution of ILC3s in autoimmune and autoinflammatory diseases. Trial registration number NCT02466217 .

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: through in - depth immunophenotypic analysis, re - evaluate and classify the relationship between autoimmune diseases (AD) and autoinflammatory diseases (AIF) to verify whether these diseases do indeed exist on a continuum from pure autoimmunity to pure autoinflammation, and identify immune cell populations and molecular targets that can distinguish different disease clusters. Specifically, the researchers hope: 1. **Verify the hypothesis**: Verify the hypothesis proposed by McGonagle and McDermott regarding the existence of a continuum between autoimmune diseases and autoinflammatory diseases. 2. **Identify disease clusters**: Use unsupervised and supervised analysis methods to identify clusters of different diseases and their common and specific cellular parameters. 3. **Characterize biomarkers**: Determine immune cell populations that can accurately characterize these disease clusters, thereby providing new biological bases for disease diagnosis and treatment. ### Main research background and known information - **Autoimmune diseases and autoinflammatory diseases**: These two types of diseases are a group of heterogeneous diseases. Currently, the classification is not clear, and there is a lack of radical treatment methods. - **Continuum hypothesis**: Some studies have shown that these diseases may exist on a continuum from pure autoimmunity to pure autoinflammation, but this hypothesis has not been systematically verified yet. - **Deficiencies in existing research**: Currently, only a few studies have systematically evaluated the differences between AD and AIF, which limits the verification of the continuum hypothesis and the identification of relevant immunological components. ### Research methods - **Sample collection**: Blood samples were collected from 443 patients with 15 different autoimmune or autoinflammatory diseases and 71 healthy volunteers. - **In - depth immunophenotypic analysis**: Use 13 flow cytometry panels to analyze more than 600 innate and adaptive immune cell populations. - **Data analysis**: Adopt unsupervised and supervised analysis methods, including hierarchical clustering, principal component analysis (PCA) and multidimensional scaling analysis (MDS), to identify disease clusters and key cellular parameters. ### Main findings - **Five types of disease clusters**: Unsupervised clustering divided these diseases into five clusters, and each cluster has common and specific cellular parameters. - **Two immunological axes**: PCA analysis revealed two main immunological axes. The first axis is driven by the ratio of LAG3 + to ICOS + in T regulatory cells (Tregs), reflecting the inflammation level of the disease; the second axis is driven by activated Tregs and type 3 innate lymphoid cells (ILC3s), reflecting the tissue types affected by the disease. - **Key cell populations**: 23 cell populations were identified, which are affected in at least seven diseases, mainly related to Tregs, effector T cells (Teffs), B cells and ILCs. ### Potential impacts - **New classification system**: Based on in - depth immunophenotypic analysis, a new classification system for autoimmune and autoinflammatory diseases is proposed. - **Directions for further research**: Call for further research on the role of the LAG3 +/ICOS + balance in Tregs and the contribution of ILC3s in autoimmune and autoinflammatory diseases. - **Treatment strategies**: Propose that patients within the same cluster may benefit from the same treatment method. In conclusion, this study, through in - depth immunophenotypic analysis of a large number of patients, provides new evidence to support the continuum hypothesis between autoimmune and autoinflammatory diseases, and provides potential biomarkers and treatment targets for future clinical treatment.

Deep immunophenotyping reveals that autoimmune and autoinflammatory disorders are spread along two immunological axes capturing disease inflammation levels and types

A nosology of immune diseases from deep immunophenotyping

Mapping the genetic landscape of disorders on the autoimmune-autoinflammatory continuum: potential implications for classification and treatment

Identifying Hidden Drivers Of Heterogeneous Inflammatory Skin Diseases

P048 Deep phenotyping of the peripheral immune cell compartment in Crohn‘s Disease

Integration of Phenomics and Transcriptomics Data to Reveal Drivers of Inflammatory Processes in the Skin

Deep Analysis of the Peripheral Immune System in IBD Reveals New Insight in Disease Subtyping and Response to Monotherapy or Combination Therapy

Clinical and multi-omics cross-phenotyping of patients with autoimmune and autoinflammatory diseases: the observational TRANSIMMUNOM protocol

High-Dimensional Analysis Reveals Distinct Endotypes in Patients With Idiopathic Inflammatory Myopathies

Identification of common genetic factors and immune-related pathways associating more than two autoimmune disorders: implications on risk, diagnosis, and treatment

How underappreciated autoinflammatory (innate immunity) mechanisms dominate disparate autoimmune disorders

Systemic autoimmune disease patients′ blood immunome reveals specificities and commonalities among different diagnostic entities

3D chromatin-based variant-to-gene maps across 57 human cell types reveal the cellular and genetic architecture of autoimmune disease susceptibility

Clinical correlates of lifetime and current comorbidity patterns in autoimmune and inflammatory diseases

Comparative single-cell multiplex immunophenotyping of therapy-naive patients with rheumatoid arthritis, systemic sclerosis, and systemic lupus erythematosus shed light on disease-specific composition of the peripheral immune system

Identification of a 5-Plex Cytokine Signature that Differentiates Patients with Multiple Systemic Inflammatory Diseases

Genetic mapping across autoimmune diseases reveals shared associations and mechanisms

Dynamic regulatory elements in single-cell multimodal data capture autoimmune disease heritability and implicate key immune cell states

Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotyping

Integrative transcriptomic analysis of SLE reveals IFN-driven cross-talk between immune cells

Single-Cell RNA-Sequencing Integration Analysis Revealed Immune Cell Heterogeneity in Five Human Autoimmune Diseases